Table 4. Cox regression analyses for predictors of outcome (BCSS and DM).
BCSS |
DM |
|||||||
---|---|---|---|---|---|---|---|---|
95% CI |
95% CI |
|||||||
Parameters | P-value | HR | Lower | Upper | P-value | HR | Lower | Upper |
Tumour stage | <0.0001 | 1.92 | 1.7 | 2.2 | <0.0001 | 1.8 | 1.6 | 1.9 |
Tumour grade | <0.001 | 1.87 | 1.5 | 2.3 | 0.034 | 1.2 | 1.01 | 1.3 |
Tumour size | 0.001 | 1.07 | 1.03 | 111 | 0.206 | 1.03 | 0.98 | 1.09 |
KPNA2 | 0.221 | 1.15 | 0.87 | 1.4 | 0.227 | 1.2 | 0.92 | 1.4 |
Adjuvant therapy subgroup | ||||||||
Tumour stage | <0.0001 | 2.05 | 1.7 | 2.5 | <0.0001 | 1.8 | 1.6 | 1.9 |
Tumour grade | <0.001 | 2.30 | 1.6 | 3.3 | 0.034 | 1.2 | 1.01 | 1.3 |
Tumour size | 0.087 | 1.18 | 0.98 | 1.3 | 0.206 | 1.03 | 0.98 | 1.09 |
KPNA2 | 0.300 | 1.13 | 0.87 | 1.6 | 0.227 | 1.2 | 0.92 | 1.4 |
No adjuvant therapy subgroup | ||||||||
Tumour stage | 0.006 | 1.64 | 1.1 | 2.3 | 0.001 | 1.6 | 1.2 | 2.1 |
Tumour grade | <0.001 | 1.75 | 1.3 | 2.4 | 0.206 | 1.1 | 0.9 | 1.4 |
Tumour size | <0.001 | 1.58 | 1.2 | 2.0 | 0.004 | 1.3 | 1.1 | 1.6 |
KPNA2 | 0.826 | 1.05 | 0.7 | 1.7 | 0.168 | 1.3 | 0.9 | 1.8 |
Abbreviations: BCSS=breast cancer-specific survival; CI=confidence interval; DM=distant metastasis; HR=hazard ratio; KPNA2=karyopherin α-2.